BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17581717)

  • 1. Diagnostic performance of CT, PET, side-by-side, and fused image interpretations for restaging of non-Hodgkin lymphoma.
    Nogami M; Nakamoto Y; Sakamoto S; Fukushima K; Okada T; Saga T; Higashi T; Senda M; Matsui T; Sugimura K
    Ann Nucl Med; 2007 Jun; 21(4):189-96. PubMed ID: 17581717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
    Nakamoto Y; Sakamoto S; Okada T; Senda M; Higashi T; Saga T; Togashi K
    AJR Am J Roentgenol; 2007 Jan; 188(1):257-67. PubMed ID: 17179375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
    Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    la Fougère C; Hundt W; Bröckel N; Pfluger T; Haug A; Scher B; Hacker M; Hahn K; Reiser M; Tiling R
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1417-25. PubMed ID: 16858568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
    Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS
    J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal status of malignant lymphoma in pelvic and retroperitoneal lymphatic pathways: comparison of integrated PET/CT with or without contrast enhancement.
    Morimoto T; Tateishi U; Maeda T; Arai Y; Nakajima Y; Edmund Kim E
    Eur J Radiol; 2008 Sep; 67(3):508-13. PubMed ID: 17904324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.
    Römer W; Nömayr A; Greess H; Fiedler E; Platsch G; Schuler-Thurner B; Pfahlberg A; Hothorn T; Schuler G; Hornegger J; Bautz W; Kuwert T
    Nuklearmedizin; 2006; 45(2):88-95. PubMed ID: 16547570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma.
    Fueger BJ; Yeom K; Czernin J; Sayre JW; Phelps ME; Allen-Auerbach MS
    Mol Imaging Biol; 2009; 11(4):269-74. PubMed ID: 19326177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
    Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease.
    Furth C; Denecke T; Steffen I; Ruf J; Voelker T; Misch D; Vondran F; Plotkin M; Stöver B; Henze G; Lemke AJ; Amthauer H
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):501-12. PubMed ID: 16912590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic evaluation of separately acquired PET and CT images by nuclear medicine physicians and radiologists in cancer patients.
    Quarles van Ufford HM; Quekel LG; van Waes PF; de Haas PJ; de Klerk JM
    Hell J Nucl Med; 2007; 10(2):105-8. PubMed ID: 17684586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
    Hernandez-Maraver D; Hernandez-Navarro F; Gomez-Leon N; Coya J; Rodriguez-Vigil B; Madero R; Pinilla I; Martin-Curto LM
    Br J Haematol; 2006 Nov; 135(3):293-302. PubMed ID: 17032175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restaging of patients with lymphoma. Comparison of low dose CT (20 mAs) with contrast enhanced diagnostic CT in combined [18F]-FDG PET/CT.
    la Fougère C; Pfluger T; Schneider V; Hacker M; Bröckel N; Morhard D; Hundt W; Bartenstein P; Becker C; Tiling R
    Nuklearmedizin; 2008; 47(1):37-42. PubMed ID: 18278211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
    Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
    Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.
    Halpern BS; Schiepers C; Weber WA; Crawford TL; Fueger BJ; Phelps ME; Czernin J
    Chest; 2005 Oct; 128(4):2289-97. PubMed ID: 16236886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
    Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.